Paul Connolly - Smith Nephew Pres Operations

All Insiders . USA . 
Stock . Smith Nephew plc . Stakeholders . Insider . Paul Connolly
SNNUF Stock  USD 12.05  0.85  6.59%   

Insider

Paul Connolly is Pres Operations of Smith Nephew plc
Age 55
Phone44 1923 477 100
Webhttps://www.smith-nephew.com

Smith Nephew Management Efficiency

The company has return on total asset (ROA) of 0.0425 % which means that it generated a profit of $0.0425 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0925 %, meaning that it generated $0.0925 on every $100 dollars invested by stockholders. Smith Nephew's management efficiency ratios could be used to measure how well Smith Nephew manages its routine affairs as well as how well it operates its assets and liabilities.
Smith Nephew plc has accumulated 2.71 B in total debt with debt to equity ratio (D/E) of 0.54, which is about average as compared to similar companies. Smith Nephew plc has a current ratio of 1.74, which is within standard range for the sector. Debt can assist Smith Nephew until it has trouble settling it off, either with new capital or with free cash flow. So, Smith Nephew's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Smith Nephew plc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Smith to invest in growth at high rates of return. When we think about Smith Nephew's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Preston WellsStryker
N/A
Willem AppeloKoninklijke Philips NV
60
Leandro MazzoniKoninklijke Philips NV
N/A
Lisa EarnhardtAbbott Laboratories
54
Heisz StoneEdwards Lifesciences Corp
58
Elisabeth StaudingerSiemens Healthineers AG
53
Jennifer KirkMedtronic PLC
49
Christian KlaussnerSiemens Healthineers AG
N/A
Marc KoebernickSiemens Healthineers AG
N/A
Nitin GoyalZimmer Biomet Holdings
N/A
Alejandro WellischAbbott Laboratories
49
Jereme SylvainDexCom Inc
44
Christopher ScogginsAbbott Laboratories
54
Feike SijbesmaKoninklijke Philips NV
62
Andre HartungSiemens Healthineers AG
N/A
Michel DVMSiemens Healthineers AG
62
Sammy KaramAbbott Laboratories
59
James YoungAbbott Laboratories
N/A
Indra NooyiKoninklijke Philips NV
66
Spencer StilesStryker
47
MSc MDMedtronic PLC
N/A
Smith Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. Smith Nephew plc was founded in 1856 and is headquartered in Watford, the United Kingdom. Smith Nephew operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 18000 people. Smith Nephew plc [SNNUF] is a Pink Sheet which is traded between brokers as part of OTC trading.

Management Performance

Return On Equity0.0925
Return On Asset0.0425

Smith Nephew plc Leadership Team

Elected by the shareholders, the Smith Nephew's board of directors comprises two types of representatives: Smith Nephew inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Smith. The board's role is to monitor Smith Nephew's management team and ensure that shareholders' interests are well served. Smith Nephew's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Smith Nephew's outside directors are responsible for providing unbiased perspectives on the board's policies.
Alison Parkes, Chief Officer
Paul Connolly, Pres Operations
Deepak Nath, CEO Director
Joe Metzger, VP Communications
Andrew Swift, VP Relations
AnneFrancoise Nesmes, CFO Director
Helen Barraclough, Company Counsel
Elga Lohler, Chief Human Resource Officer
Bradley Cannon, Sports Orthopaedics
Philip Cowdy, Chief Officer

Smith Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Smith Nephew a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0925
Return On Asset0.0425
Profit Margin0.1 %
Operating Margin0.14 %
Current Valuation14.08 B
Shares Outstanding873.35 M
Shares Owned By Insiders0.17 %
Shares Owned By Institutions52.60 %
Price To Earning23.41 X
Price To Book2.12 X

Currently Active Assets on Macroaxis

CCitigroup
GMGeneral Motors
FFord Motor
GMGeneral Motors
VVisa Class A

Other Information on Investing in Smith Pink Sheet

Smith Nephew financial ratios help investors to determine whether Smith Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Smith with respect to the benefits of owning Smith Nephew security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY